Neurava Raises $2.26M for Wearable Devices, Funds Pivotal Study and Manufacturing
Neurava Raises $2.26M in Seed Funding
Neurava's Seed Funding for Wearable Devices
Key Highlights:
- Seed Funding: Neurava, an Indianapolis-based MedTech startup, raised $2.26 million in seed funding.
- Investors: Funding led by Life Science Angels, with participation from UCB, Purdue Innovates, Elevate Ventures, Rivermount Ventures, and First Leaf Capital.
- Product Development: Funding will support completion of a pivotal usability study, manufacturing partnerships, and FDA clearance for Neurava's smart wearables.
Neurava's Target Market
- Target Market: Individuals suffering from epilepsy, including both adults and pediatric patients.
- Clinical Institutions: Collaboration opportunities with leading clinical institutions for usability studies and validation of Neurava's wearable devices.
- Healthcare Providers and Specialists: Neurologists, epileptologists, and other healthcare professionals involved in epilepsy diagnosis and treatment.
What Neurava Needs to Buy
- Manufacturing Partners: Partnerships with manufacturers for the production of Neurava's smart wearable devices.
- Regulatory Compliance Services: Assistance in obtaining FDA clearance and navigating regulatory requirements for medical devices.
- Marketing and Distribution Support: Expertise in marketing and distribution to reach healthcare providers and potential customers worldwide.